Executives from Alphatec (NASDAQ:ATEC) outlined the company’s strategy for “long-term differentiated growth” during a presentation at a JPMorgan healthcare conference, highlighting recent financial performance, a continued emphasis on procedure-focused product design, and an expanding role for data
Alphatec Touts 2026 Growth Plan at JPMorgan Conference, Guides to $890M Revenue and $20M FCF
January 14, 2026
You may also like
Indices by TradingView
Amazon vs. Costco: Which Stock Is a Better Buy?
February 28, 2026
Cross Staff Loads Up on 289,000 Shares of AKRE
February 28, 2026
The billion-dollar infrastructure deals powering the AI boom
February 28, 2026
AI Boom May Be Creating Hidden Risks In Housing Market
February 28, 2026
Categories
Indices by TradingView





